328 related articles for article (PubMed ID: 11514696)
1. Aerosolised iloprost improves pulmonary haemodynamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatment.
Petkov V; Ziesche R; Mosgoeller W; Schenk P; Vonbank K; Stiebellehner L; Raderer M; Brunner C; Kneussl M; Block LH
Thorax; 2001 Sep; 56(9):734-6. PubMed ID: 11514696
[TBL] [Abstract][Full Text] [Related]
2. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.
Olschewski H; Walmrath D; Schermuly R; Ghofrani A; Grimminger F; Seeger W
Ann Intern Med; 1996 May; 124(9):820-4. PubMed ID: 8610951
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment of pulmonary hypertension with aerosolized iloprost.
Machherndl S; Kneussl M; Baumgartner H; Schneider B; Petkov V; Schenk P; Lang IM
Eur Respir J; 2001 Jan; 17(1):8-13. PubMed ID: 11307761
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group.
Hoeper MM; Olschewski H; Ghofrani HA; Wilkens H; Winkler J; Borst MM; Niedermeyer J; Fabel H; Seeger W
J Am Coll Cardiol; 2000 Jan; 35(1):176-82. PubMed ID: 10636277
[TBL] [Abstract][Full Text] [Related]
5. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
[TBL] [Abstract][Full Text] [Related]
6. Role of Vasodilator Testing in Pulmonary Hypertension.
Sharma A; Obiagwu C; Mezue K; Garg A; Mukherjee D; Haythe J; Shetty V; Einstein AJ
Prog Cardiovasc Dis; 2016; 58(4):425-33. PubMed ID: 26434988
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation.
Opitz CF; Wensel R; Bettmann M; Schaffarczyk R; Linscheid M; Hetzer R; Ewert R
Eur Heart J; 2003 Feb; 24(4):356-65. PubMed ID: 12581683
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
[TBL] [Abstract][Full Text] [Related]
9. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbruck B; Grimminger F; Seeger W
Am J Respir Crit Care Med; 1999 Aug; 160(2):600-7. PubMed ID: 10430735
[TBL] [Abstract][Full Text] [Related]
10. Sustained improvement of performance and haemodynamics with long-term aerosolised prostacyclin therapy in severe pulmonary hypertension.
Stricker H; Domenighetti G; Fiori G; Mombelli G
Schweiz Med Wochenschr; 1999 Jun; 129(24):923-7. PubMed ID: 10413827
[TBL] [Abstract][Full Text] [Related]
11. Intravenous iloprost for treatment failure of aerosolised iloprost in pulmonary arterial hypertension.
Hoeper MM; Spiekerkoetter E; Westerkamp V; Gatzke R; Fabel H
Eur Respir J; 2002 Aug; 20(2):339-43. PubMed ID: 12212965
[TBL] [Abstract][Full Text] [Related]
12. Rapid transition from inhaled iloprost to inhaled treprostinil in patients with pulmonary arterial hypertension.
Bourge RC; Tapson VF; Safdar Z; Benza RL; Channick RN; Rosenzweig EB; Shapiro S; White RJ; McSwain CS; Gotzkowsky SK; Nelsen AC; Rubin LJ
Cardiovasc Ther; 2013 Feb; 31(1):38-44. PubMed ID: 22970909
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension.
Wang L; Jin YZ; Zhao QH; Jiang R; Wu WH; Gong SG; He J; Liu JM; Jing ZC
Int J Chron Obstruct Pulmon Dis; 2017; 12():3353-3360. PubMed ID: 29200842
[TBL] [Abstract][Full Text] [Related]
14. Aerosolized iloprost therapy could not replace long-term IV epoprostenol (prostacyclin) administration in severe pulmonary hypertension.
Schenk P; Petkov V; Madl C; Kramer L; Kneussl M; Ziesche R; Lang I
Chest; 2001 Jan; 119(1):296-300. PubMed ID: 11157622
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension.
Leuchte HH; Schwaiblmair M; Baumgartner RA; Neurohr CF; Kolbe T; Behr J
Chest; 2004 Feb; 125(2):580-6. PubMed ID: 14769741
[TBL] [Abstract][Full Text] [Related]
16. Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension.
Stiebellehner L; Petkov V; Vonbank K; Funk G; Schenk P; Ziesche R; Block LH
Chest; 2003 Apr; 123(4):1293-5. PubMed ID: 12684325
[TBL] [Abstract][Full Text] [Related]
17. [Prostacyclin and iloprost in aerosol form in severe pulmonary hypertension].
Olschewski H; Walmrath D; Schermuly R; Ghofrani HA; Grimminger F; Seeger W
Pneumologie; 1998 Jan; 52(1):3-7. PubMed ID: 9540363
[No Abstract] [Full Text] [Related]
18. Hemodynamic effects of combination therapy with inhaled nitric oxide and iloprost in patients with pulmonary hypertension and right ventricular dysfunction after high-risk cardiac surgery.
Antoniou T; Koletsis EN; Prokakis C; Rellia P; Thanopoulos A; Theodoraki K; Zarkalis D; Sfyrakis P
J Cardiothorac Vasc Anesth; 2013 Jun; 27(3):459-66. PubMed ID: 23063102
[TBL] [Abstract][Full Text] [Related]
19. Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group.
Olschewski H; Ghofrani HA; Schmehl T; Winkler J; Wilkens H; Höper MM; Behr J; Kleber FX; Seeger W
Ann Intern Med; 2000 Mar; 132(6):435-43. PubMed ID: 10733442
[TBL] [Abstract][Full Text] [Related]
20. Ventilation/perfusion ratios in pulmonary arterial hypertension: effects of IV and inhaled prostacyclin derivatives.
Bratel T; Lagerstrand L; Brodin LA; Nowak J; Randmaa I
Chest; 2005 Dec; 128(6 Suppl):615S-616S. PubMed ID: 16373868
[No Abstract] [Full Text] [Related]
[Next] [New Search]
